| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
47,373 |
33,914 |
$1.30M |
| 88307 |
|
6,273 |
4,204 |
$225K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
5,867 |
4,284 |
$108K |
| 88312 |
|
2,294 |
1,721 |
$85K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,396 |
3,249 |
$82K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,265 |
3,228 |
$82K |
| 88141 |
|
3,340 |
2,457 |
$42K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
419 |
341 |
$39K |
| 88142 |
|
3,011 |
2,181 |
$38K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,706 |
1,273 |
$30K |
| 88342 |
|
1,106 |
793 |
$24K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,706 |
1,278 |
$24K |
| 87653 |
|
741 |
630 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
568 |
379 |
$16K |
| 88304 |
|
904 |
707 |
$11K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
133 |
128 |
$11K |
| 87481 |
|
591 |
281 |
$9K |
| 87511 |
|
328 |
283 |
$6K |
| 88341 |
|
114 |
83 |
$4K |
| 87081 |
|
720 |
608 |
$4K |
| 88112 |
|
95 |
57 |
$2K |
| 85060 |
|
31 |
27 |
$267.54 |
| 87529 |
|
39 |
37 |
$198.00 |
| 87210 |
|
17 |
13 |
$65.80 |
| 88300 |
|
15 |
13 |
$44.60 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12 |
12 |
$25.00 |
| 88302 |
|
18 |
14 |
$10.50 |